J. Harris, R. Waterston, M. Brooke, and L. Specht, Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy, N Engl J Med, vol.318, pp.1363-1368, 1988.

V. Chapman, D. Miller, D. Armstrong, and C. Caskey, Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice., Proceedings of the National Academy of Sciences, vol.86, issue.4, pp.1292-1296, 1989.
DOI : 10.1073/pnas.86.4.1292

V. Allamand and K. Campbell, Animal models for muscular dystrophy: valuable tools for the development of therapies, Human Molecular Genetics, vol.9, issue.16, pp.2459-2467, 2000.
DOI : 10.1093/hmg/9.16.2459

G. Ferrari, A. Stornaiuolo, and F. Mavilio, Failure to correct murine muscular dystrophy, Nature, vol.411, issue.6841, pp.1014-1015, 2001.
DOI : 10.1038/35082631

A. Connolly, R. Keeling, S. Mehta, A. Pestronk, and J. Sanes, Three mouse models of muscular dystrophy: the natural history of strength and fatigue in dystrophin-, dystrophin/utrophin-, and laminin ??2-deficient mice, Neuromuscular Disorders, vol.11, issue.8, pp.703-712, 2001.
DOI : 10.1016/S0960-8966(01)00232-2

R. Gherardi, In vivo fusion of circulating fluorescent cells with dystrophin-deficient myofibers results in extensive sarcoplasmic fluorescence expression but limited dystrophin sarcolemmal expression, Am J Pathol, vol.166, pp.1741-1748, 2005.

D. Duan, Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy, Human Molecular Genetics, vol.15, issue.Review Issue 2, pp.253-261, 2006.
DOI : 10.1093/hmg/ddl180

B. Petrof, J. Shrager, H. Stedman, A. Kelly, and H. Sweeney, Dystrophin protects the sarcolemma from stresses developed during muscle contraction., Proceedings of the National Academy of Sciences, vol.90, issue.8, pp.3710-3714, 1993.
DOI : 10.1073/pnas.90.8.3710

B. Petrof, Dystrophin-deficient cardiomyocytes are abnormally vulnerable to mechanical stress-induced contractile failure and injury, Faseb J, vol.15, pp.1655-1657, 2001.

D. Townsend, S. Yasuda, and J. Metzger, Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach, Expert Review of Cardiovascular Therapy, vol.5, issue.1, pp.99-109, 2007.
DOI : 10.1586/14779072.5.1.99

T. Rando, M. Disatnik, Y. Yu, and A. Franco, Muscle cells from mdx mice have an increased susceptibility to oxidative stress, Neuromuscular Disorders, vol.8, issue.1, pp.14-21, 1998.
DOI : 10.1016/S0960-8966(97)00124-7

A. Bitto, A. Mazzeo, H. Marini, F. Squadrito, and G. Vita, Lipid peroxidation inhibition blunts nuclear factor-kappaB activation, reduces skeletal muscle degeneration, and enhances muscle function in mdx mice, Am J Pathol, vol.168, pp.918-926, 2006.

J. Tidball and M. Wehling-henricks, The role of free radicals in the pathophysiology of muscular dystrophy, Journal of Applied Physiology, vol.102, issue.4, pp.1677-1686, 2007.
DOI : 10.1152/japplphysiol.01145.2006

T. Rando, Role of nitric oxide in the pathogenesis of muscular dystrophies: A ?two hit? hypothesis of the cause of muscle necrosis, Microscopy Research and Technique, vol.24, issue.4, pp.223-235, 2001.
DOI : 10.1002/jemt.1172

T. Buetler, R. M. Offord, E. Schneider, H. Ruegg, and U. , Green tea extract decreases muscle necrosis in mdx mice and protects against reactive oxygen species, Am J Clin Nutr, vol.75, pp.749-753, 2002.

N. Whitehead, C. Pham, O. Gervasio, and D. Allen, mice, The Journal of Physiology, vol.562, issue.7, pp.2003-2014, 2008.
DOI : 10.1113/jphysiol.2007.148338

C. Pavoine and F. Pecker, Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology, Cardiovascular Research, vol.82, issue.2, pp.175-183, 2009.
DOI : 10.1093/cvr/cvp030
URL : https://hal.archives-ouvertes.fr/inserm-00371935

J. Su, S. Adubeiro, F. Roudot-thoraval, J. Dubois-rande, L. Hittinger et al., Nacetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats, Circulation, vol.110, pp.2003-2009, 2004.

C. Pavoine, P. Caramelle, R. Souktani, L. Corvoisier, P. Perier et al., Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats, J Mol Cell Cardiol, vol.43, pp.344-353, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00158065

F. Thoraval, J. Dubois-rande, L. Hittinger, C. Pavoine, and F. Pecker, Glutathione deficiency in cardiac patients is related to the functional status and structural cardiac abnormalities HL: L-gamma-Glutamyl-L-cysteinyl-glycine (glutathione, PLoS ONE, vol.4, pp.4871-4894, 2009.

D. Townsend, K. Tew, and H. Tapiero, The importance of glutathione in human disease, Biomedicine & Pharmacotherapy, vol.57, issue.3-4, pp.145-155, 2003.
DOI : 10.1016/S0753-3322(03)00043-X

R. Franco, O. Schoneveld, A. Pappa, and M. Panayiotidis, The central role of glutathione in the pathophysiology of human diseases, Archives of Physiology and Biochemistry, vol.134, issue.4-5, pp.234-258, 2007.
DOI : 10.1182/blood-2003-12-4299

D. Degl-'innocenti, F. Rosati, T. Iantomasi, M. Vincenzini, and G. Ramponi, GSH system in relation to redox state in dystrophic skin fibroblasts, Biochimie, vol.81, issue.11, pp.1025-1029, 1999.
DOI : 10.1016/S0300-9084(99)00334-X

J. Finsterer and C. Stollberger, The Heart in Human Dystrophinopathies, Cardiology, vol.99, issue.1, pp.1-19, 2003.
DOI : 10.1159/000068446

J. Quinlan, H. Hahn, B. Wong, J. Lorenz, A. Wenisch et al., Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings, Neuromuscular Disorders, vol.14, issue.8-9, pp.491-496, 2004.
DOI : 10.1016/j.nmd.2004.04.007

P. Goldschmidt-clermont and J. Loscalzo, Heterozygous cellular glutathione peroxidase deficiency in the mouse: abnormalities in vascular and cardiac function and structure, Circulation, vol.106, pp.1154-1158, 2002.

B. Topkaya and S. Nebioglu, Increased oxidative stress in dilated cardiomyopathic heart failure, Clin Chem, vol.44, pp.148-154, 1998.

K. Tanaka, S. Totsuka, W. Takasaki, and S. Manabe, A novel model of continuous depletion of glutathione in mice treated with L-buthionine (S,R)-sulfoximine, J Toxicol Sci, vol.28, pp.455-469, 2003.

C. Pastoret and A. Sebille, Age-related differences in regeneration of dystrophic (mdx) and normal muscle in the mouse, Muscle & Nerve, vol.104, issue.10, pp.1147-1154, 1995.
DOI : 10.1002/mus.880181011

J. Mcgeachie, M. Grounds, T. Partridge, and J. Morgan, Age-related changes in replication of myogenic cells in mdx mice: Quantitative autoradiographic studies, Journal of the Neurological Sciences, vol.119, issue.2, pp.169-179, 1993.
DOI : 10.1016/0022-510X(93)90130-Q

G. Nigro, L. Comi, A. Palladino, V. Petretta, and L. Politano, Cardiomyopathies: diagnosis of types and stages, Acta Myol, vol.23, pp.97-102, 2004.

H. , D. Clarke, and K. , Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy, J Am Coll Cardiol, vol.36, pp.1953-1958, 2000.

I. Danko, V. Chapman, and J. Wolff, The Frequency of Revertants in mdx Mouse Genetic Models for Duchenne Muscular Dystrophy, Pediatric Research, vol.32, issue.1, pp.128-131, 1992.
DOI : 10.1203/00006450-199207000-00025

J. Lang and R. , Accuracy of echocardiographic estimates of left ventricular mass in mice, Am J Physiol Heart Circ Physiol, vol.280, pp.1954-1962, 2001.

L. Rappaport, K. Schwartz, and P. Menasche, Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function, J Thorac Cardiovasc Surg, vol.119, pp.1169-1175, 2000.

F. Tietze, Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues, Analytical Biochemistry, vol.27, issue.3, pp.502-522, 1969.
DOI : 10.1016/0003-2697(69)90064-5

I. Rahman, A. Kode, and S. Biswas, Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method, Nature Protocols, vol.63, issue.6, pp.3159-3165, 2006.
DOI : 10.1038/nprot.2006.378

V. Deveaux, M. Bourin, A. Zimmer, S. Lotersztajn, F. Pecker et al., The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy AF: Real-time PCR based on SYBR-Green I fluorescence: an alternative to 21, Faseb J, vol.43, 2009.

M. Hunter and J. Mohamed, Plasma antioxidants and lipid peroxidation products in Duchenne muscular dystrophy, Clinica Chimica Acta, vol.155, issue.2, pp.123-131, 1986.
DOI : 10.1016/0009-8981(86)90273-1

M. Rodriguez and M. Tarnopolsky, Patients with dystrophinopathy show evidence of increased oxidative stress, Free Radical Biology and Medicine, vol.34, issue.9, pp.1217-1220, 2003.
DOI : 10.1016/S0891-5849(03)00141-2

I. Williams and D. Allen, The role of reactive oxygen species in the hearts of dystrophin-deficient mdx mice, AJP: Heart and Circulatory Physiology, vol.293, issue.3, pp.1969-1977, 2007.
DOI : 10.1152/ajpheart.00489.2007

N. Kar and C. Pearson, Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle, Clinica Chimica Acta, vol.94, issue.3, pp.277-280, 1979.
DOI : 10.1016/0009-8981(79)90076-7

C. Pastoret and . Sebille, mdx mice show progressive weakness and muscle deterioration with age, Journal of the Neurological Sciences, vol.129, issue.2, pp.97-105, 1995.
DOI : 10.1016/0022-510X(94)00276-T

G. Lynch, R. Hinkle, J. Chamberlain, S. Brooks, and J. Faulkner, mice 6-28 months old, The Journal of Physiology, vol.104, issue.2, pp.591-600, 2001.
DOI : 10.1111/j.1469-7793.2001.00591.x

D. Lowe, B. Williams, D. Thomas, and R. Grange, Molecular and cellular contractile dysfunction of dystrophic muscle from young mice, Muscle & Nerve, vol.460, issue.1, pp.92-100, 2006.
DOI : 10.1002/mus.20562

J. Metzger, Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure, Mol Ther, vol.15, pp.1086-1092, 2007.

V. Kakkar, Chronic fatigue syndrome: physical and cardiovascular deconditioning, Qjm, vol.91, pp.475-481, 1998.

K. Miwa and M. Fujita, Small Heart Syndrome in Patients with Chronic Fatigue Syndrome, Clinical Cardiology, vol.15, issue.7, pp.328-333, 2008.
DOI : 10.1002/clc.20227

K. Clarke, Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy, J Mol Cell Cardiol, vol.31, pp.1857-1862, 1999.

G. Nigro, L. Comi, L. Politano, and R. Bain, The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy, International Journal of Cardiology, vol.26, issue.3, pp.271-277, 1990.
DOI : 10.1016/0167-5273(90)90082-G

R. Mantegazza and P. Confalonieri, Immunomodulation of TGF-beta 1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: implications for antifibrotic therapy, J Neuroimmunol, vol.175, pp.77-86, 2006.

I. Lankhorst, M. Sardina, and G. Boissard, Lung function in idiopathic pulmonary fibrosis-extended analyses of the IFIGENIA trial, Respir Res, vol.10, p.101, 2009.